Is diphenhydramine (Benadryl) safe to use during the first trimester of pregnancy?

Diphenhydramine (Benadryl) Safety in First Trimester Pregnancy

Diphenhydramine can be used during the first trimester of pregnancy, though it should be used with caution due to an unresolved concern about a possible association with cleft palate, despite recent large studies showing no increased risk of major congenital malformations.

Evidence-Based Recommendation

The FDA drug label explicitly states "do not use if pregnant or breast-feeding" 1, which creates a direct contradiction with clinical practice guidelines. However, clinical guidelines from the Journal of Allergy and Clinical Immunology (2008) provide more nuanced guidance that should inform real-world practice [@1-7,9-10@].

Key Safety Data

First-generation antihistamines, including diphenhydramine, have generally excellent safety records:

• Both first- and second-generation antihistamines show no significant increase in congenital malformations when used during the first trimester [@2-7,9@]
• However, a specific caveat exists for diphenhydramine: Although it is frequently used by pregnant patients and recent studies have not detected increased risk for congenital malformations, there remains concern over a case-control study suggesting an association with cleft palate that "has yet to be sufficiently refuted" [@1-7,9@]

Supporting Research Evidence

Large-scale research studies provide reassuring data:

• A 2017 meta-analysis of H1 antihistamines found no increased risk of major malformation (OR 1.07; 95% CI 0.98-1.16), spontaneous abortion, prematurity, stillbirth, or low birth weight 2
• A 2013 study examining 13,213 infants with malformations found no meaningful support for previously posited associations between antihistamines and major congenital anomalies 3
• A 2020 analysis of 41,148 pregnancies showed lack of strong evidence to conclude birth defects are associated with antihistamine exposure during early pregnancy 4

Clinical Decision Algorithm

When considering diphenhydramine in first trimester:

1. First, consider safer alternatives:

   • Chlorpheniramine is often chosen by clinicians due to its long safety record and is frequently recommended as a first-choice agent [@2-7,9@]
   • Second-generation antihistamines (loratadine, cetirizine) have confirmed safety through large birth registries and are FDA Pregnancy Category B 5

2. If diphenhydramine is chosen:

   • Counsel the patient about the theoretical cleft palate concern (absolute risk remains very low)
   • Use the lowest effective dose for the shortest duration necessary
   • Document the risk-benefit discussion

3. Avoid combining with:

   • Oral decongestants (phenylephrine, pseudoephedrine) which should be avoided in first trimester due to associations with gastroschisis and small intestinal atresia [@1-7,9-10@]
   • Acetaminophen or salicylates when combined with decongestants [@1-7,9-10@]

Important Caveats

Critical timing consideration: The first trimester is when organogenesis occurs, making this the most critical period for concern about potential congenital malformations from medication use [@2-7,9@].

The cleft palate concern in context:

• This association comes from older case-control data
• Multiple recent large studies have not confirmed this finding
• The absolute risk, if real, remains very small
• The concern has "yet to be sufficiently refuted" according to guidelines, meaning uncertainty persists [@1-7,9@]

Practical reality: Diphenhydramine is "often used by pregnant patients" and has "good overall safety data" despite the theoretical concern [@1,10@]. Approximately 4.2% of pregnant women use diphenhydramine during first trimester based on surveillance data 3.

Preferred Alternatives for First Trimester

Better first-line options include:

• Chlorpheniramine: Long safety record, though sedating [@2-7,9@]
• Loratadine or cetirizine: FDA Category B, confirmed safety in large registries 5
• Intranasal corticosteroids: Safe and effective profile for allergic symptoms [@1,4,10@]
• Sodium cromolyn: Safe treatment, though requires frequent dosing [@2,4,6-7,9@]

The evidence suggests that while diphenhydramine is likely safe, the unresolved cleft palate signal warrants preferential use of alternatives when equally effective options exist.